CorMedix Long Term Deferred Assets (Quarterly) Analysis

CorMedix, Inc. (CRMD)

6.78 -0.23 (-3.28%) USD | NASDAQ | Jan 16, 16:00

6.75 -0.03 (-0.44%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for CRMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
Pfizer Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	--
ANI Pharmaceuticals, Inc.	Upgrade
Alkermes Plc	Upgrade